Browsing Wolfson Institute of Preventive Medicine by Author "Vergote, I"
Now showing items 1-3 of 3
-
Predicting distant recurrence of ER+HER2-breast cancer after 5 years of endocrine therapy: The CTS5-tool validation in real life
Van Cauwenberge, J; Sestak, I; Punie, K; Wildiers, H; Floris, G; Vergote, I; Berteloot, P; Van Gorp, T; Smeets, A; Van Nieuwenhuysen, E (2020-02) -
Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II.
Oonk, MH; Slomovitz, B; Baldwin, P; Vergote, I; Sharma, A; Manchanda, RThe Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V)-II investigated whether inguinofemoral radiotherapy is a safe alternative to inguinofemoral lymphadenectomy (IFL) in vulvar cancer patients ... -
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe.
Van der Kolk, WL; Van der Zee, AGJ; Slomovitz, BM; Baldwin, PJW; Van Doorn, HC; De Hullu, JA; Van der Velden, J; Gaarenstroom, KN; Slangen, BFM; Kjolhede, P (2022-10)OBJECTIVE: Optimal management of the contralateral groin in patients with early-stage vulvar squamous cell carcinoma (VSCC) and a metastatic unilateral inguinal sentinel lymph node (SN) is unclear. We analyzed patients who ...